Literature DB >> 10570692

Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder.

C K Conners1.   

Abstract

Rating scales for the diagnosis and treatment of ADHD capture a lot of information at a relatively low cost and are of particular value in pediatric settings. They identify the expectations for children at a given age and gender for most behavioral problems encountered in practice. Used appropriately, these rating scales help to avoid some of the excesses decried by critics and the controversies. This article reviews problems in diagnoses, problems in treatment, methodology of rating scales, a description of new scales, a diagnostic utility of new scales.

Entities:  

Mesh:

Year:  1999        PMID: 10570692     DOI: 10.1016/s0031-3955(05)70159-0

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  23 in total

1.  Disrupted brain functional networks in drug-naïve children with attention deficit hyperactivity disorder assessed using graph theory analysis.

Authors:  Ying Chen; Xiaoqi Huang; Min Wu; Kaiming Li; Xinyu Hu; Ping Jiang; Lizhou Chen; Ning He; Jing Dai; Song Wang; Manxi He; Lanting Guo; John A Sweeney; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2019-07-30       Impact factor: 5.038

Review 2.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 3.  Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder.

Authors:  J Barton
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

4.  Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.

Authors:  Frances R Levin; John J Mariani; Sheila Specker; Marc Mooney; Amy Mahony; Daniel J Brooks; David Babb; Yun Bai; Lynn E Eberly; Edward V Nunes; John Grabowski
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

5.  Frontal systems related symptoms in cocaine dependent patients with comorbid personality disorders.

Authors:  Natalia Albein-Urios; José Miguel Martínez-González; Oscar Lozano; Antonio Verdejo-Garcia
Journal:  Psychopharmacology (Berl)       Date:  2013-03-13       Impact factor: 4.530

Review 6.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 7.  Treatment strategies for co-occurring ADHD and substance use disorders.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Addict       Date:  2007

8.  Decision-making impairment predicts 3-month hair-indexed cocaine relapse.

Authors:  Antonio Verdejo-Garcia; Natalia Albein-Urios; Jose Miguel Martinez-Gonzalez; Ester Civit; Rafael de la Torre; Oscar Lozano
Journal:  Psychopharmacology (Berl)       Date:  2014-04-13       Impact factor: 4.530

9.  Prenatal exposure to dental amalgam and risk of symptoms of attention-deficit and hyperactivity disorder (ADHD).

Authors:  Gunvor B Lygre; Heidi Aase; Kjell Haug; Stein A Lie; Lars Björkman
Journal:  Community Dent Oral Epidemiol       Date:  2018-08-07       Impact factor: 3.383

10.  White matter alterations at 33-year follow-up in adults with childhood attention-deficit/hyperactivity disorder.

Authors:  Samuele Cortese; Davide Imperati; Juan Zhou; Erika Proal; Rachel G Klein; Salvatore Mannuzza; Maria A Ramos-Olazagasti; Michael P Milham; Clare Kelly; F Xavier Castellanos
Journal:  Biol Psychiatry       Date:  2013-04-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.